Back to directory

Atomwise Pitch Deck

Stage

Series B

Industry

Healthcare

Year

2020

Updated

March 11, 2026

Raised

$123M

Company detail

Atomwise uses artificial intelligence to accelerate drug discovery and development. Their platform analyzes vast datasets to identify potential drug candidates, significantly reducing the time and cost associated with traditional research methods. This Series B deck was used to raise $123 million. Atomwise has since raised additional funding and continues to advance its AI-driven approach to creating new medicines.